Australia markets closed

Odyssey Health, Inc. (ODYY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0350+0.0020 (+6.06%)
At close: 12:46PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0330
Open0.0390
BidN/A x N/A
AskN/A x N/A
Day's range0.0350 - 0.0390
52-week range0.0210 - 0.2350
Volume41,500
Avg. volume101,914
Market cap3.373M
Beta (5Y monthly)-0.44
PE ratio (TTM)0.35
EPS (TTM)0.1000
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate

    TAMPA, Fla. & LAS VEGAS, October 05, 2023--Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company") and Odyssey Health, Inc. (OTCQB: ODYY) ("Odyssey") announce the signing of a definitive agreement under which Oragenics will acquire Odyssey’s assets related to its proprietary neurological drug therapies and technologies. The assets include drug candidates for treating mild traumatic brain injury (mTBI), also known as concussion, and for treating Niemann Pick Disease Type C (NPC), as